Membrane-Tethered Proteins for Basic Research, Imaging, and Therapy

被引:19
作者
Cheng, Tian-Lu [2 ]
Roffler, Steve [1 ]
机构
[1] Acad Sinica, Inst Biomed Sci, Taipei 11529, Taiwan
[2] Kaohsiung Med Univ, Fac Biomed Sci & Environm Biol, Kaohsiung, Taiwan
关键词
surface expression; transmembrane domain; GPI-anchor; single-chain antibody; membrane protein; prodrugs; imaging; chimeric proteins;
D O I
10.1002/med.20127
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Secreted and intracellular proteins including antibodies, cytokines, major histocompatibility complex Molecules, antigens, and enzymes can be redirected to and anchored on the surface of mammalian cells to reveal novel functions and properties such as reducing systemic toxicity, altering the in vivo distribution of drugs and extending the range of useful drugs,creating novel, specific signaling receptors and reshaping protein immunogenicity. The present review highlights progress in designing vectors to target and retain chimeric proteins on the surface of mammalian cells. Comparison of chimeric proteins indicates that selection of the proper cytoplasmic domain and introduction of oligiosaccharides near the cell surface can dramatically enhance Surface expression, especially for single-chain antibodies. We also describe progress and limitations of employing surface-tethered proteins for preferential activation of prodrugs at cancer cells, imaging gene expression in living animals, performing high-throughput screening, selectively activating immune cells in tumors, producing new adhesion molecules, creating local immune privileged sites, limiting the distribution of soluble factors such as cytokines, and enhancing polypeptide immunogenicity. Surface-anchored chimeric proteins represent a rich source for developing new techniques and creating novel therapeutics. (C) 2008 Wiley Periodicals, Inc. Med Res Rev, 28, No. 6, 885-928, 2008
引用
收藏
页码:885 / 928
页数:44
相关论文
共 198 条
[1]  
ADAM D, 1993, J BIOL CHEM, V268, P19882
[2]   An immunoglobulin Cκ-reactive single chain antibody fusion protein induces tolerance through receptor editing in a normal polyclonal immune system [J].
Ait-Azzouzene, D ;
Verkoczy, L ;
Peters, J ;
Gavin, A ;
Skog, P ;
Vela, JL ;
Nemazee, D .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 201 (05) :817-828
[3]   Qualitative and quantitative differences in T cell receptor binding of agonist and antagonist ligands [J].
Alam, SM ;
Davies, GM ;
Lin, CM ;
Zal, T ;
Nasholds, W ;
Jameson, SC ;
Hogquist, KA ;
Gascoigne, NRJ ;
Travers, PJ .
IMMUNITY, 1999, 10 (02) :227-237
[4]   Transgenic expression of CD95 ligand on islet beta cells induces a granulocytic infiltration but does not confer immune privilege upon islet allografts [J].
Allison, J ;
Georgiou, HM ;
Strasser, A ;
Vaux, DL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (08) :3943-3947
[5]   VACCINIA ROTAVIRUS-VP7 RECOMBINANTS PROTECT MICE AGAINST ROTAVIRUS-INDUCED DIARRHEA [J].
ANDREW, ME ;
BOYLE, DB ;
COUPAR, BEH ;
REDDY, D ;
BELLAMY, AR ;
BOTH, GW .
VACCINE, 1992, 10 (03) :185-191
[6]   THE IMMUNOGENICITY OF VP7, A ROTAVIRUS ANTIGEN RESIDENT IN THE ENDOPLASMIC-RETICULUM, IS ENHANCED BY CELL-SURFACE EXPRESSION [J].
ANDREW, ME ;
BOYLE, DB ;
WHITFELD, PL ;
LOCKETT, LJ ;
ANTHONY, ID ;
BELLAMY, AR ;
BOTH, GW .
JOURNAL OF VIROLOGY, 1990, 64 (10) :4776-4783
[7]   Vascular leak syndrome: a side effect of immunotherapy [J].
Baluna, R ;
Vitetta, ES .
IMMUNOPHARMACOLOGY, 1997, 37 (2-3) :117-132
[8]   CHIMERIC TUMOR-NECROSIS-FACTOR RECEPTORS WITH CONSTITUTIVE SIGNALING ACTIVITY [J].
BAZZONI, F ;
ALEJOS, E ;
BEUTLER, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (12) :5376-5380
[9]   Membrane-anchored β2-microglobtilin stabilizes a highly receptive state of MHC class I molecules [J].
Berko, D ;
Carmi, Y ;
Cafri, G ;
Ben-Zaken, S ;
Sheikhet, HM ;
Tzehoval, E ;
Eisenbach, L ;
Margalit, A ;
Gross, G .
JOURNAL OF IMMUNOLOGY, 2005, 174 (04) :2116-2123
[10]   Human monocytes expressing a CEA-specific chimeric CD64 receptor specifically target CEA-expressing tumour cells in vitro and in vivo [J].
Biglari, A ;
Southgate, TD ;
Fairbairn, LJ ;
Gilham, DE .
GENE THERAPY, 2006, 13 (07) :602-610